Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A New Generation of Gene Therapies as the Future of Wet AMD Treatment

17 Feb 2024

Abstract excerpt

Age-related macular degeneration (AMD) is an eye disease and the most common cause of vision loss in the Western World. In its advanced stage, AMD occurs in two clinically distinguished forms, dry and wet, but only wet AMD is treatable. However, the treatment based on repeated injections with vascular endothelial growth factor A (VEGFA) antagonists may at best stop the disease progression and prevent or delay...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Retinal and Optic Conditions
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38397064
DOI: 10.3390/ijms25042386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A New Generation of Gene Therapies as the Future of Wet AMD TreatmentPMID 38397064Read ↗

New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity Read ↗

Gene therapy for age-related macular degeneration: a promising frontier in vision preservationSemantic proximity Read ↗

Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and BeyondSemantic proximity Read ↗

Preclinical development of a dual targeting bicistronic gene therapy approach for the treatment of wet age-related macular degenerationSemantic proximity Read ↗

Gene therapy for age-related macular degenerationSemantic proximity Read ↗

A Systematic Review; Efficacy Assessment of Novel Therapy in Treating Age-related Macular DegenerationSemantic proximity Read ↗

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular DegenerationSemantic proximity Read ↗

AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy TherapiesSemantic proximity Read ↗

The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewSemantic proximity Read ↗

Targeting vascular endothelial growth factor using retinal gene therapySemantic proximity Read ↗

Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and ProgressSemantic proximity Read ↗

Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.